These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole versus other atypical antipsychotics for schizophrenia. Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570 [TBL] [Abstract][Full Text] [Related]
9. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480 [TBL] [Abstract][Full Text] [Related]
12. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Fonseka TM; Richter MA; Müller DJ Curr Psychiatry Rep; 2014 Nov; 16(11):510. PubMed ID: 25256097 [TBL] [Abstract][Full Text] [Related]
13. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Schirmbeck F; Esslinger C; Rausch F; Englisch S; Meyer-Lindenberg A; Zink M Psychol Med; 2011 Nov; 41(11):2361-73. PubMed ID: 21466748 [TBL] [Abstract][Full Text] [Related]
14. Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism. Yesilkaya UH; Balcioglu YH J Clin Psychopharmacol; 2020; 40(4):412-414. PubMed ID: 32433255 [No Abstract] [Full Text] [Related]
15. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111 [TBL] [Abstract][Full Text] [Related]
16. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. Scheltema Beduin AA; Swets M; Machielsen M; Korver N; J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156 [TBL] [Abstract][Full Text] [Related]
17. Classics in Chemical Neuroscience: Aripiprazole. Casey AB; Canal CE ACS Chem Neurosci; 2017 Jun; 8(6):1135-1146. PubMed ID: 28368577 [TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814 [TBL] [Abstract][Full Text] [Related]